Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4845 SEK | -1.02% |
|
-2.71% | +6.13% |
08:30am | Active Biotech Enters Agreement for A Clinical Study of Tasquinimod in Myelofibrosis | CI |
05-22 | Active Biotech Secures Exclusive Licensing Rights to Multiple Myeloma Drug | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Neutral | Neutral |
Resistance | 0.5960 | 1.102 | 0.9800 |
Spread/Res. | -18.71% | -56.03% | -50.56% |
Spread/Supp. | +0.94% | +7.79% | +7.67% |
Support | 0.4800 | 0.4495 | 0.4500 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- ACTI Stock
- Charts Active Biotech AB